Ain Holdings

Basic Information

Stock Code
9627
Industry
Retail
Category Detail
Specialty Stores & Drugstores
Prefecture
Hokkaido
Establishment Year
August 1969
Listing Year
March 1994
Official Website
https://www.ainj.co.jp/
TSE Information
TSE Information
Yahoo! Finance
Yahoo! Finance
Other Companies
Pharmarise Holdings, Quoll Holdings, Cosmos Pharmacy, Welcia, Nihon Chouzai, Medical Ikko Group, Tsuruha HD, F&F, Medical System Network, Mia Health Holdings, ＨＹＵＧＡ　ＰＲＩＭＡＲＹ　ＣＡＲＥ, Sapporo Clinical Laboratory Center

Overview

Ain Holdings is a leading holding company in the retail industry, established in 1969, that deploys dispensing pharmacies and drugstores nationwide, primarily centered in northern Japan, the Kanto, and Kansai regions.

Current Situation

Ain Holdings recorded consolidated sales of approximately ¥399.8 billion and operating profit of ¥20.4 billion for the fiscal year ending April 2024, operating numerous stores from Hokkaido to the Kanto and Kansai regions as Japan's largest dispensing pharmacy chain. Its core dispensing pharmacy division maintains a stable revenue base through steady prescription handling, while its drugstore chain continues to grow by addressing diverse needs. Since transitioning to a holding company structure in 2015, it has expanded its pharmacy network, including Nishinippon Pharmacy, and pursued multifaceted service development. In 2024, it brought the interior goods business Francfranc under its umbrella to expand business areas and achieve synergy effects. Certified as a Health Management Excellence Corporation by the Ministry of Economy, Trade and Industry, it is committed to employee diversity and welfare improvements. While strengthening operations through M&A and business alliances, it is enhancing community-based services and has set a mid-term strategy aiming for sales exceeding ¥700 billion in fiscal 2025. It is also focusing on efficiency improvements through ICT utilization and strengthened collaboration with regional healthcare.

Trivia

Interesting Facts

  • Founded in the 1970s in Hokkaido as the First Clinical Laboratory Center.
  • Transitioned to holding company in 2015 to strengthen group management.
  • Entered household goods business in 2024 via Francfranc acquisition.
  • Pioneering company that explicitly states LGBT support in its internal action guidelines.
  • Certified as METI Health Management Excellence Corporation 2024.
  • Owns numerous dispensing pharmacy and drugstore chains under its umbrella.
  • Strengthening consulting and pharmacist dispatch business for medical institutions.
  • Sponsor company of Hokkaido REIT Investment Corporation.
  • Advancing regional medical collaboration through partnership with JR Hokkaido.
  • Boasts top-class scale in domestic dispensing pharmacy sales.
  • Has broad customer touchpoints through diverse sales channels.
  • Balances community-based management with nationwide deployment.
  • Aggressively introducing IT for management efficiency.
  • Conducts annual employee satisfaction surveys to promote health management.
  • Performance progressing on growth trajectory leveraging M&A.

Hidden Connections

  • Involved in real estate as sponsor of Hokkaido REIT Investment Corporation.
  • Shareholder relationships with major retailers like Seven & i, potential for collaboration.
  • Central to industry restructuring as holding company for multiple regional drug and pharmacy chains.
  • Built management system in collaboration with METI health management promotion policies.
  • Established unique domains in pharmacist dispatch and medical consulting for dispensing pharmacy business.
  • Entered lifestyle consumer goods field beyond healthcare via Francfranc acquisition.
  • LGBT support formalization implemented ahead of industry peers.
  • Frequently featured in Nikkei and Yahoo! Finance for notable M&A and management reform information.

Future Outlook

Growth Drivers

  • Increasing dispensing pharmacy demand nationwide due to aging population
  • Store network expansion and synergy effects via M&A
  • Business efficiency and customer service improvements through digitalization
  • Revenue diversification through growth in interior goods business
  • Strengthened talent acquisition via Health Management Excellence certification
  • Expansion of community-based medical and nursing care linkage services
  • Development of beauty and cosmetics market for younger demographics
  • Expansion of online sales and EC channels
  • Organizational strengthening through work style reforms and diversity support
  • Enhanced ESG (Environment, Social, Governance) response
  • New service deployment adapting to post-COVID social changes
  • Brand power enhancement through strengthened local economic collaboration

Strategic Goals

  • Achieve total sales exceeding ¥700 billion
  • Expand nationwide network centered on dispensing pharmacies
  • Further growth in household goods and interior business
  • Revolutionize customer experience and operational efficiency through digital technology
  • Achieve over 90% employee satisfaction through sustained health management
  • Reduce environmental impact through renewable energy utilization
  • Penetrate respect for diversity culture throughout the company
  • Expand nationwide deployment of medical-nursing care linkage services
  • Strengthen new market and youth-oriented product development
  • Expand community-rooted social contributions

Business Segments

Services for Medical Institutions

Overview
Provides pharmacist dispatch and management support services to medical institutions and nursing facilities.
Competitiveness
Extensive pharmacist network and understanding of medical sites
Customers
  • Hospitals
  • Clinics
  • Nursing Facilities
  • Dispensing Pharmacies
Products
  • Pharmacist Staffing Dispatch
  • Management Consulting
  • Dispensing Support Solutions
  • Pharmaceutical Supply

Wholesale - Logistics Services

Overview
Handles distribution of pharmaceuticals and hygiene products to an extensive store network.
Competitiveness
Efficient distribution network and rapid response system
Customers
  • Pharmacy Chains
  • Drugstores
  • Pharmaceutical Manufacturers
Products
  • Pharmaceutical Wholesale
  • Dispensing Pharmaceutical Delivery
  • Hygiene Product Supply

Cosmetics Sales - Development

Overview
Deploys brands such as Ayura to provide beauty-related products to the market.
Competitiveness
High-quality product development and brand strength
Customers
  • General Consumers
  • Retail Stores
  • Beauty Salons
Products
  • Cosmetics Sales
  • New Product Development
  • Brand Deployment

Household Goods Retail

Overview
Supplies and sells interior and miscellaneous goods products centered on Francfranc.
Competitiveness
Products combining design and functionality
Customers
  • General Consumers
  • Retail Chains
Products
  • Interior Products
  • Household Goods
  • Kitchenware

Dispensing Equipment - IT Related Business

Overview
Deploys IT services to support efficiency in dispensing operations.
Competitiveness
System provision tailored to medical sites
Customers
  • Dispensing Pharmacies
  • Medical Institutions
Products
  • Dispensing Support Software
  • Electronic Medical Records Linkage System

Competitive Advantage

Strengths

  • Powerful store network spanning from Hokkaido to Kanto and Kansai
  • Stable customer base as the largest in the dispensing pharmacy industry
  • Extensive product lineup through diverse brands
  • Improved management efficiency via holding company structure
  • Promotion of employee diversity support and health management
  • Aggressive M&A and business diversification strategy
  • Community-based service provision and medical collaboration
  • New entry into interior goods sector
  • Possesses management consulting and staffing dispatch for medical field
  • Certified as Health Management Excellence Corporation by local governments and METI
  • Comprehensive online and offline sales channels
  • Efforts to enhance corporate value based on long-term growth strategy
  • Work environment improvement including LGBT support
  • Product range capable of addressing wide customer needs
  • Strong financial base and stable profit recording

Competitive Advantages

  • Boasts nationwide prescription handling capacity and reliability as the largest dispensing pharmacy chain
  • Can differentiate business formats through diverse drugstore brands
  • High capability for rapid market entry and store network expansion via M&A
  • Succeeds in differentiation from competitors by providing comprehensive medical-related services
  • Strengthens talent acquisition and social credibility through Health Management Excellence certification
  • Actively promoting business efficiency through ICT and digital technology utilization
  • Strong customer base through balance of community focus and nationwide network
  • Succeeds in business diversification beyond drugstores via Francfranc acquisition
  • Achieves stable revenue structure by catering to wide customer segments
  • Internal activation through respect for diverse cultures including LGBT support
  • Strong financial base supports competitive strengthening
  • Adaptable to social needs on both sustainability and medical fronts
  • Capable of complex market deployment in health, beauty, and household goods
  • Superior in advanced dispensing technology and securing specialist pharmacists
  • Expansion of customer touchpoints through diverse sales channels

Threats

  • Risk of reduced medical and dispensing remuneration revisions
  • Ongoing intense competition within the drugstore industry
  • Fluctuations in prescription volume due to changes in regional medical systems
  • Increased operational and management costs due to stricter regulations
  • Difficulty in securing pharmacists amid labor shortages
  • Intensified market share competition from new entrants
  • Pressure on drug prices from insurance system changes
  • Risk of rising logistics and raw material costs
  • Performance fluctuations due to social events like new infectious diseases
  • Decline in competitiveness from delays in digital transformation
  • Challenges and risk management in M&A integration
  • Changes in consumer health trends affecting product demand

Innovations

2024: Entry into Household Goods Business via Francfranc Acquisition

Overview
Acquired lifestyle goods brand Francfranc for ¥50 billion to expand non-medical business areas.
Impact
Successfully opened new business areas and diversified revenue.

2023: Formalization of LGBT Support Employee Guidelines

Overview
Institutionalized internal LGBT support to strengthen respect for diversity.
Impact
Contributes to workplace environment improvement and talent acquisition.

2020: Acquisition and Integration of Sidax Eye Co., Ltd.

Overview
Made Sidax Eye a subsidiary to expand facility management business for medical institutions.
Impact
Strengthened comprehensive medical services.

2022: Management Strengthening under Holding Company Structure

Overview
Systematized group management under holding company to improve operational efficiency.
Impact
Improved decision-making speed and resource allocation efficiency.

2021: Enhanced Preparation for Health Management Excellence Certification

Overview
Deepened health management initiatives to establish foundation for certification.
Impact
Improved employee health awareness and increased corporate value.

Sustainability

  • Promoting employee health and creating a comfortable workplace
  • Contributing to local communities through collaboration with regional healthcare
  • Logistics efficiency improvements and packaging material reductions to lessen environmental impact
  • Establishing respect for diversity (LGBT support) in corporate culture
  • Strengthening governance for sustainable business operations
  • Thorough pharmaceutical safety management and legal compliance
  • Providing local employment opportunities and economic support
  • Promoting plastic reduction and recycling activities
  • Actively conducting health education and awareness activities
  • Establishing medical support systems for disasters
  • Promoting utilization of digital health technologies in medical field
  • Improving transparency and information disclosure in CSR activities